In the current series, compared to patients with ≥2 metastatic sites, we observed no improvement in OS of patients with one metastatic site and a slight benefit in CSS, which did not reach statistical significance.
← all excerpts
Survival predictors of metastatic angiosarcomas: a surveillance, epidemiology, and end results program population-based retrospective study.
1
—
—